🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
7.04
-0.20 (-2.76%)
At close: Nov 20, 2026, 4:00 PM EST
7.03
-0.01 (-0.14%)
After-hours: Nov 20, 2026, 7:30 PM EST

Evommune Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Evommune stock has a consensus rating of "Buy" and an average price target of $21.89. The average 1-year stock price forecast is 210.94% higher than the current stock price, while the lowest is $8.00 (+13.64%) and the highest is $28 (+297.73%).

Price Target: $21.89 (+210.94%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$8.00$21.89$22$28
Change+13.64%+210.94%+212.50%+297.73%

Analyst Ratings

The average analyst rating for Evommune stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy555555
Buy334444
Hold222233
Sell000000
Strong Sell000000
Total101011111212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Leerink Partners
Leerink Partners
Buy
Reiterates
$22
BuyReiterates$22+212.50%Nov 16, 2026
RBC Capital
RBC Capital
Buy
Maintains
$21
BuyMaintains$21+198.30%Nov 13, 2026
H.C. Wainwright
H.C. Wainwright
Hold
Reiterates
n/a
HoldReiteratesn/an/aNov 13, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$26 → $23
BuyMaintains$26 → $23+226.70%Nov 13, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$30
BuyMaintains$30+326.14%Nov 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
625.00K
from 13.00M
Decreased by -95.19%
Revenue Next Year
875.00K
from 625.00K
Increased by 40.00%
EPS This Year
-3.28
from -11.22
EPS Next Year
-3.42
from -3.28
Fiscal YearFY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
5.00M7.00M13.00M625.00K
Revenue Growth
-40.00%85.71%-95.19%
Gross Profit
5.00M7.00M13.00M625.00K
Gross Margin
100.00%100.00%100.00%100.00%
Operating Income
-37.85M-70.01M-81.07M-129.86M
Net Income
-34.05M-66.81M-68.87M-120.49M
EPS
---11.22-3.28
Free Cash Flow
---76.68M-105.00M
No. Analysts
---8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High5.0M
Avg625,000
Lown/a

Revenue Growth

Revenue Growth202620272028
High
-61.5%
Avg
-95.2%
Low
-100.0%

EPS Forecast

EPS202620272028
High-2.71
Avg-3.28
Low-3.65

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-